A federal agency is facing allegations of wrongdoing. The claims involve a large quantity of a potent drug. Details about the situation are limited, but it is known that an investigation has been requested.

This inquiry will be conducted by an internal watchdog. Further information about the allegations and the investigation can be found through news sources, including KPRC 2 and Click2Houston, which reported on the matter.